Supplemental Figure 1

5
Supplemental Figure 1 Fold change 0 200 400 600 800 1000 1200 centralendosteal 0 40 80 120 160 200 centralendosteal 0 5 10 15 20 25 30 35 centralendosteal 0 10 20 30 40 50 60 central endosteal osterix opn bsp osteocalcin *** *** *** ***

TAGS:

description

Supplemental Figure 1. osterix. opn. bsp. osteocalcin. ***. 60. 35. 200. 1200. ***. ***. ***. 30. 50. 1000. 160. 25. 40. 800. 120. 20. Fold change. 600. 30. 15. 80. 400. 20. 10. 40. 200. 10. 5. 0. 0. 0. 0. central. endosteal. central. endosteal. central. - PowerPoint PPT Presentation

Transcript of Supplemental Figure 1

Page 1: Supplemental Figure 1

Supplemental Figure 1

Fo

ld c

ha

ng

e

0200

400

600

8001000

1200

central endosteal0

40

80

120

160

200

central endosteal05

101520253035

central endosteal0

10

20

30

40

50

60

central endosteal

osterix opn bsp osteocalcin

*** *** *** ***

Page 2: Supplemental Figure 1

0

50

100

150

200

central endosteal0

0.10.20.30.40.50.60.7

central endosteal

CF

U-F

/10

6 ce

lls

CF

U-F

AL

P+

(%

)A CB**

Supplemental Figure 2

central endosteal

Page 3: Supplemental Figure 1

Supplemental Figure 3

A

B

C

i ii

i ii

i ii

Page 4: Supplemental Figure 1

CD105 CD45CD29Sca-1

Supplemental Figure 4

cen

tra

le

nd

ost

ea

lA CD166 CD73 CD71 CD44 CD34

99.8% 70.5% 96.7% 12.4%57.4% 97.0% 93.1% 100.0% 5.51%

0.9%95.8%42.1%59.4%46.5%99.8% 81.9% 91.7% 25.1%

growth

cen

tra

le

nd

ost

ea

l

OB growth AD

B Cce

ntr

al

en

do

ste

al

Page 5: Supplemental Figure 1

A

AL

P-

AL

P+

PTHvehCB

veh PTH

0

0.5

1.0

1.5

2.0

2.5

veh PTH

ALP- ALP+C

FU

-F/1

06

cells

CF

U-F

dia

me

ter

(mm

)

Supplemental Figure 5

veh PTH

CF

U-F

/10

6 ce

llsD

** **

**

EPTH

OB

growthce

ntr

al

en

do

ste

al

veh PTH

AD

growth veh

04080

120

160200220

020406080

100120140

ALP- ALP+


Supplemental Figure 1

Supplemental Figure 1

Supplemental Figure 1.

Supplemental Figure 1.

BolteusBordey Supplemental Figure 1

BolteusBordey Supplemental Figure 1

Supplemental Figure Legends: Supplemental Figure S1 ...genesdev.cshlp.org/content/suppl/2014/07/11/gad... · Supplemental Figure Legends: Supplemental Figure S1 Vernalization response

Supplemental Figure Legends: Supplemental Figure S1 ...genesdev.cshlp.org/content/suppl/2014/07/11/gad... · Supplemental Figure Legends: Supplemental Figure S1 Vernalization response

Supplemental Figure 1.

Supplemental Figure 1.

1. Supplemental Figure 1 - International Journal of ... · Supplemental Figure 1 2. Supplemental Figure 2 3. Supplemental Figure 3 4. Supplemental Figure 4 5. Supplemental Figure

1. Supplemental Figure 1 - International Journal of ... · Supplemental Figure 1 2. Supplemental Figure 2 3. Supplemental Figure 3 4. Supplemental Figure 4 5. Supplemental Figure

Supplemental Tables and Supplemental Figure Legends...2014/04/14  · 1 Supplemental Tables and Supplemental Figure Legends 2 3 Supplementary Figure Legends 4 5 Figure S1. SDS-PAGE

Supplemental Tables and Supplemental Figure Legends...2014/04/14  · 1 Supplemental Tables and Supplemental Figure Legends 2 3 Supplementary Figure Legends 4 5 Figure S1. SDS-PAGE

SUPPLEMENTAL FIGURE LEGENDS Supplemental Figure 1 (A,B) (C ...dm5migu4zj3pb.cloudfront.net/manuscripts/65000/65899/JCI65899sd.pdf · Supplemental Figure 1 Siglec-7 and -9 ligand expression

SUPPLEMENTAL FIGURE LEGENDS Supplemental Figure 1 (A,B) (C ...dm5migu4zj3pb.cloudfront.net/manuscripts/65000/65899/JCI65899sd.pdf · Supplemental Figure 1 Siglec-7 and -9 ligand expression

Figure legends: Supplemental Figure 1 A) TAA;

Figure legends: Supplemental Figure 1 A) TAA;

Supplemental Figure 1 - Journal of CancerSupplemental Figure 2 . Supplemental Figure 3 . Supplemental Table 1. Relationship between CD4 TIL expression and various patient characteristics

Supplemental Figure 1 - Journal of CancerSupplemental Figure 2 . Supplemental Figure 3 . Supplemental Table 1. Relationship between CD4 TIL expression and various patient characteristics

Supplemental data: Supplemental Figure 1. Sequence of ...

Supplemental data: Supplemental Figure 1. Sequence of ...

List of Supplemental Digital Content Supplemental Figure 1 ...

List of Supplemental Digital Content Supplemental Figure 1 ...

Supplemental Figure 1 A. · Supplemental Figure 1 A. B. Let-7 target site C. miR-103/107 target site . 2 Supplemental Figure 2 . 3 Supplemental Figure 3 . 4 Supplemental Figure 4

Supplemental Figure 1 A. · Supplemental Figure 1 A. B. Let-7 target site C. miR-103/107 target site . 2 Supplemental Figure 2 . 3 Supplemental Figure 3 . 4 Supplemental Figure 4

Supplemental Digital Content Supplemental Figure 1 ...

Supplemental Digital Content Supplemental Figure 1 ...

Supplemental figure 1: Dapul_304363

Supplemental figure 1: Dapul_304363

Supplemental Figure 1

Supplemental Figure 1

Supplemental Figure 1. Supplemental Figure 2 Supplemental Figure 3 A B.

Supplemental Figure 1. Supplemental Figure 2 Supplemental Figure 3 A B.

SUPPLEMENTAL FIGURE LEGEND - Weeblydimitrovagen677s09.weebly.com/uploads/1/7/2/1/...1 SUPPLEMENTAL FIGURE LEGEND Supplemental Figure 1. Absence of cardiac developmental abnormalities

SUPPLEMENTAL FIGURE LEGEND - Weeblydimitrovagen677s09.weebly.com/uploads/1/7/2/1/...1 SUPPLEMENTAL FIGURE LEGEND Supplemental Figure 1. Absence of cardiac developmental abnormalities

Supplemental Figure Legend Supplemental Figure 1 A · Supplemental Figure Legend Supplemental Figure 1 (A) Principal component analysis of gene expression of Panc-1 and BxPC3 cells.All

Supplemental Figure Legend Supplemental Figure 1 A · Supplemental Figure Legend Supplemental Figure 1 (A) Principal component analysis of gene expression of Panc-1 and BxPC3 cells.All

SUPPLEMENTAL FIGURE LEGENDS Supplemental Fig… · SUPPLEMENTAL FIGURE LEGENDS Supplemental Fig. 1. ... Schematic representation of zebrafish ATX gene with exons ... LPA 1 MO caused

SUPPLEMENTAL FIGURE LEGENDS Supplemental Fig… · SUPPLEMENTAL FIGURE LEGENDS Supplemental Fig. 1. ... Schematic representation of zebrafish ATX gene with exons ... LPA 1 MO caused